Home > Riviste > International Angiology > Fascicoli precedenti > Articles online first > International Angiology 2021 Jul 20

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

International Angiology 2021 Jul 20

DOI: 10.23736/S0392-9590.21.04726-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Time course of microvalve pathophysiology in high pressure low flow model of venous insufficiency and the role of micronized purified flavonoid fraction

Cyrino F. de ALMEIDA 1, Vanessa BLANC-GUILEMAUD 2 , Eliete BOUSKELA 1

1 Laboratory for Clinical and Experimental Research on Vascular Biology (BioVasc), State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2 Translational Medicine Division, Institut de Recherches Internationales Servier, Suresnes, France



BACKGROUND: The aim of this study was to characterize, in an experimental model, the mechanisms involved in the initiation of venous insufficiency at the level of microvenous valve and whether they can be influenced by early treatment with micronized purified flavonoid fraction (MPFF).
METHODS: The external right iliac vein of 78 male golden Syrian hamsters was ligated to induce chronic venous insufficiency. Internal venular diameter as well as leukocyteendothelium-interaction (leukocytes sticking after staining with rhodamine 6G), were assessed using an intravital microscope. In the second part of the study 30 animals were divided into three groups and underwent: ligation plus MPFF, ligation plus 10% lactose solution (vehicle), or sham operation. Treatment with MPFF 100 mg/kg/day or vehicle started 2 days before ligation and lasted for 7 days. Venular diameter and number of adherent leukocytes were assessed 5 days post-ligature.
RESULTS: Venule diameter increased immediately after ligature and reached a maximum at 4 hours (P<0.001 vs baseline), followed by a plateau before gradually returning to baseline dimensions. The increase in the number of adherent leukocytes was also immediate but attained maximal number at 3 days (p<0.0001), followed by a plateau and then gradual return to baseline numbers. In MPFF-treated animals, leukocyte adhesion to the microvalves was prevented compared with vehicle-treated animals (p<0.0001) and venule diameter was also significantly reduced (p<0.05).
CONCLUSIONS: Venous hypertension induced immediate venule dilatation followed by an increase in the number of adherent leukocytes at microvalve level. Treatment with MPFF prevented the initiation of microvalve inflammation and may play a protective role in the progression of chronic venous insufficiency.


KEY WORDS: Chronic venous disease; Inflammation; Micronized purified flavonoid fraction; Microvalve; Venoactive; Venous hypertension

inizio pagina